-
Mashup Score: 1GN’s Jabra sends self-fitting hearing aids to market for $799 ahead of FDA over-the-counter ruling - 2 year(s) ago
The Enhance Plus earbuds have been cleared by the FDA as self-fitting hearing aids.
Source: FierceBiotechCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Tasso, Vault Health team up to provide at-home blood testing for siteless clinical trials - 2 year(s) ago
Tasso’s push-button blood collection device attaches to the upper arm and draws a sample from the skin’s capillaries.
Source: FierceBiotechCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 2Remote possibilities: United BioSource teams with Seqster to boost decentralized study offering - 2 year(s) ago
Decentralized trials are here to stay, says United BioSource, which has partnered with “patient centric” healthcare tech firm Seqster PDM to bolster its remote study business.
Source: FierceBiotechCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 2Tasso, Vault Health team up to provide at-home blood testing for siteless clinical trials - 2 year(s) ago
Tasso’s push-button blood collection device attaches to the upper arm and draws a sample from the skin’s capillaries.
Source: FierceBiotechCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 342Pfizer's $130M Lyme disease vaccine advances to phase 3 after 3rd shot shown to increase antibodies - 2 year(s) ago
Pfizer is taking its Valneva-partnered Lyme disease vaccine into phase 3. With midphase data supporting a three-dose series, the allies plan to kick off a phase 3 clinical trial of the regimen in the third quarter.
Source: FierceBiotechCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 2
Provention Bio has won the go-ahead from the FDA to resubmit its application for a therapy to delay diabetes, which has been on hold since the agency questioned whether the planned commercial product was comparable to the drug used in historical trials.
Source: FierceBiotechCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0Does the world need more COVID-19 vaccines? These companies think there's still room for improvement - 2 year(s) ago
The ultimate COVID-19 vaccine will be able to tackle all emerging coronavirus strains, easy to store and quick to manufacture. And yes, there’s still time for the stragglers who were beaten to the punch by Pfizer, BioNTech and Moderna—at least according to the companies still trying to get in line.
Source: FierceBiotechCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Doctor groups urge Biden administration to disclose costs of federally funded clinical trials - 2 year(s) ago
International nonprofits and doctor groups are calling for the U.S. government to disclose the cost of federally funded clinical trials and are urging President Joe Biden to nominate a National Institutes of Health director who will ensure biopharmas reveal that R&D figure to the public.
Source: FierceBiotechCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
Sensor maker Rockley Photonics reported that a pilot study of its wrist-worn device was able to measure a person’s blood pressure without the squeeze of a cuff.
Source: FierceBiotechCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
The algorithm looks for changes in the tiny blood vessels feeding the back of the eye and the complex patterns linked to broader cardiovascular disease.
Source: FierceBiotechCategories: Future of Medicine, Latest HeadlinesTweet
GN’s @Jabra_US sends self-fitting #hearingaids to market for $799 ahead of #FDA over-the-counter #OTC ruling https://t.co/1wwPCjkM7C